There have been recent media reports about a potential new treatment for dry macular degeneration using an old drug that was originally developed to treat HIV.
The treatment is from a class of drug known as Nucleoside Reverse Transcriptase Inhibitors (NRTIs).
To date, the only trials that have been conducted involve mice. While promising, these trials must be treated with a degree of caution as mice do not have a macula.
The results could be very different when the drug is investigated in humans.
Extensive human trials are now underway, however the Foundation is not aware of any trial sites in Australia at this time.
If you have further questions, please contact the Foundation on 1800 111 709.
5 December 2014